Effects of drugs on growth hormone secretion regulation
https://doi.org/10.14341/probl11965
Abstract
The authors have assessed the effects of 7 metabolic and 5 neutral drugs and their combinations on the basal blood concentration of the growth hormone (GH) and on the sensitivity of GH-regulating centers to homeostatic glucose inhibition. No significant changes in GH basal level were revealed. Nacom and a combination of vitamins E and C reduced the threshold sensitivity to glucose inhibition of the GH, whereas miscleron and trental elevated this threshold sensitivity. A combination of butamid and nacom had the highest stimulatory effect on the cellular immunity and macrophagal function, that may be mediated by enhanced GH secretion. In subjects with the ‘superior’ (android) type of obesity GH basal concentration and its sensitivity to glucose inhibition were lower than in those with the ‘inferior’ (gynoid) type, this being true after the drug discontinuation.
About the Authors
L. M. BersteinRussian Federation
V. В. Gamayunova
Russian Federation
T. Ye. Poroshina
Russian Federation
N. N. Simonov
Russian Federation
A. V. Gulyayev
Russian Federation
A. D. Leonchuk
Russian Federation
V. M. Dilman
Russian Federation
References
1. Васюкова Е. А., Зефирова Г. С., Касаткин Ю. Н. и др. // III Всесоюзный съезд эндокринологов.— М., 1972.— С. 322.
2. Дильман В. М. Четыре модели медицины,—Л., 1987.
3. Дильман В. М, Берштейн Л. A., Цырлина Е. В., Ревской С. Ю. // Гормоны в экспериментальной и клинической онкологии.— М. — 1990.
4. Корнева Е. А, Шхинек Э. К. Гормоны и иммунная система.— Л., 1988.
5. Порошина Т. Е., Ревской С. Ю., Дильман В. М. // Лабораторная диагностика в клинической практике.— Л., 1982. — С. 402—407.
6. Dilman К М., Berstein L. M., Yevtushenko T. P. et al. // Arch. Geschwulstforsch.— 1988.— Bd 58, N 3.— S. 175— 183.
7. Diquez C.. Page M. D., Scanlon M. F. // Clin. Edocr.— 1988.— Vol. 28, N 1,— P. 109—143.
8. Emerman J. T., Leahhy M., Gout P. W., Bruchowsky N. // Horm. Metab. Res.— 1985,— Vol. 17, N 4.— P. 421—425.
9. Gil-Ad I., Gurewitz R., Marcovici O. et al. // Mech. Ageins Develop.— 1984,— Vol. 27, N 1,— P. 97—100.
10. Imaki T, Shibasaki T., Shizume K. et al. //J. clin. Endocr. Metab.— 1985 — Vol. 60, N 2,— P. 290—293.
11. Lucke C, Adelman N., Glick S. M. // Ibid.— 1972.— Vol. 35, N 3,— P. 407—412.
12. Maestri Е., Gamellini L., Rossi G. et al. // Horm. Metab. Res.— 1985,— Vol. 17, N 5,— P. 482—488.
13. Mendelson W. B., Jacobs L. S., Gillin J. C., Wyatt R. J. // Psychineuroendocrinology.— 1979.— Vol. 4, N 4.— P. 341 — 349.
14. Parker D. C., Rossman L. G. // J. clin. Endocr.— 199L— Vol. 32, N 1.— P. 65—68.
15. Pintor C., Celia S. G., Loche S. et al. // Lancet.— 1987 —Vol. 1 .— P . 1 226—1229.
16. Rudman D., Feller A. G., Nagraj H. C. et al. // New Engl. J. Med.— 1990,—Vol. 323, N 1,—P. 1—6.
17. Schimpff R. M., Repellin A. M., Bozolla M. // C. R. Acad. Sci. Paris Ser. III.— 1989.— Vol. 309, N 1,— P. 29—34.
18. Tuomisto J., Mannisto P. // Pharmacol. Rev.— 1985.— Vol. 37, N 3,— P. 249—332.
19. Vague J., Vague Ph., Jubelin J., Barre A. /l Fat Distribution During Growth and Later Health Outcomes.— New York, 1988 — .P.9—41.
20. Zadik Z, Challu S. A., McCarter R. J. et al. // J. clin. Endocr. Metab.— 1985,— VoL 60, N 3.— P. 513—516.
Review
For citations:
Berstein L.M., Gamayunova V.В., Poroshina T.Ye., Simonov N.N., Gulyayev A.V., Leonchuk A.D., Dilman V.M. Effects of drugs on growth hormone secretion regulation. Problems of Endocrinology. 1993;39(2):18-22. (In Russ.) https://doi.org/10.14341/probl11965

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).